Taken together, these data show that although ABCC1 did not contribute to the acquired resistance to Venetoclax, inhibition of ABCC1 can restore Venetoclax sensitivity in resistant AML cells. The gene discussed is ABCC1; the disease is acute myeloid leukemia.